Treatment with a LTβR-stimulating antibody partially restored the occurrence of HECs (PNAd+ BECs) in tumor-bearing LNs and substantially improved immigration of naive T cells to a level similar as observed during control conditions (Figures 4B, 5B, and 5C). The gene discussed is LTBR; the disease is neoplasm.